These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10212826)

  • 1. Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications.
    Southgate J; Harnden P; Trejdosiewicz LK
    Histol Histopathol; 1999 Apr; 14(2):657-64. PubMed ID: 10212826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratins in normal and malignant transitional epithelium. Maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma cell culture lines.
    Moll R; Achtstätter T; Becht E; Balcarova-Ständer J; Ittensohn M; Franke WW
    Am J Pathol; 1988 Jul; 132(1):123-44. PubMed ID: 2456018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression.
    Schaafsma HE; Ramaekers FC; van Muijen GN; Lane EB; Leigh IM; Robben H; Huijsmans A; Ooms EC; Ruiter DJ
    Am J Pathol; 1990 Feb; 136(2):329-43. PubMed ID: 1689541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin expression patterns in the rat respiratory tract as markers of epithelial differentiation in inhalation toxicology. I. Determination of normal cytokeratin expression patterns in nose, larynx, trachea, and lung.
    Schlage WK; Bülles H; Friedrichs D; Kuhn M; Teredesai A
    Toxicol Pathol; 1998; 26(3):324-43. PubMed ID: 9608639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokeratins and transitional epithelium of the bladder. Particular distribution of cytokeratins].
    Fetissof F; Serres G; Haillot O
    Arch Anat Cytol Pathol; 1990; 38(4):159-62. PubMed ID: 1699500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cytokeratin and Vimentin Protein in the Genesis of Transitional Cell Carcinoma of Urinary Bladder Patients.
    Rahmani AH; Babiker AY; AlWanian WM; Elsiddig SA; Faragalla HE; Aly SM
    Dis Markers; 2015; 2015():204759. PubMed ID: 26640315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors.
    Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC
    Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotype of transitional metaplasia of the uterine cervix.
    Harnden P; Kennedy W; Andrew AC; Southgate J
    Int J Gynecol Pathol; 1999 Apr; 18(2):125-9. PubMed ID: 10202669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The altered expression of cytokeratin polypeptides in carcinomas of human bladder.
    Chen YJ; Huang CN; Wu WJ; Chiang PH; Huang CH; Chang SF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 Jan; 10(1):9-15. PubMed ID: 7513767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini.
    Chastain EC; Oliva IV; Osunkoya AO
    Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
    Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
    Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
    Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
    Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokeratin polypeptide patterns of different epithelia of the human male urogenital tract: immunofluorescence and gel electrophoretic studies.
    Achtstätter T; Moll R; Moore B; Franke WW
    J Histochem Cytochem; 1985 May; 33(5):415-26. PubMed ID: 2580881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin expression patterns in metastatic transitional cell carcinoma of the urinary tract. An immunohistochemical study comparing local tumor and autologous metastases.
    Schaafsma HE; Ramaekers FC; van Muijen GN; Robben H; Lane EB; Leigh IM; Ooms EC; Schalken JA; van Moorselaar RJ; Ruiter DJ
    Am J Pathol; 1991 Dec; 139(6):1389-400. PubMed ID: 1721491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
    Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
    Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis.
    Ishii Y; Itoh N; Takahashi A; Masumori N; Ikeda T; Tsukamoto T
    Int J Urol; 2005 Jan; 12(1):104-7. PubMed ID: 15661064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokeratins in inverted papillomas of the urinary bladder. (Part 1.)].
    Stosiek P; Kasper M; Seidenschnur A; Goertchen R
    Pathologe; 1993 Dec; 14(6):330-3. PubMed ID: 7510066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.